Fusions involving the kinase domain of previously reported partner genes were identified in 0.4% and 4.1% of MSS and MSI cancers, respectively22 (8 NTRK1, 6 BRAF, 2 ALK, 1 NTRK3 and 1 RET; Supplementary Table 11). The gene discussed is BRAF; the disease is cancer.